問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2021-07-27 - 2025-06-30
Condition/Disease
Allergic Asthma
Test Drug
FB825
Participate Sites17Sites
Not yet recruiting5Sites
Recruiting12Sites
2012-07-01 - 2020-06-30
Participate Sites11Sites
Terminated11Sites
2013-01-01 - 2015-12-31
Alzeheimer's Disease
LMTM
Participate Sites6Sites
Terminated5Sites
Study ended1Sites
Division of Neurology
2015-02-01 - 2017-12-31
Alzheimer’s Disease
Leuco-methylthioninium bis (hydromethanesulfonate) (LMTM, TRx0237)
Participate Sites4Sites
Terminated4Sites
2016-03-07 - 2017-12-31
Alzheimer’s disease
RVT-101
Participate Sites5Sites
2013-03-01 - 2019-12-31
Terminated6Sites
2018-08-23 - 2020-07-31
Hepatocellular Carcinoma (HCC)
IOP injection
Participate Sites8Sites
Not yet recruiting6Sites
Terminated1Sites
2024-07-01 - 2025-12-31
Participate Sites1Sites
Recruiting1Sites
2023-04-01 - 2026-03-31
Advanced Solid Tumor
AM-928
Participate Sites3Sites
Not yet recruiting3Sites
2020-06-01 - 2026-12-31
Intermediate stage B or limited advanced stage C hepatocellular carcinoma (HCC)
CSR02-Fab-TF
Not yet recruiting1Sites
Recruiting3Sites
全部